Hemodynamic effects of clonidine in two contrasting models of autonomic failure: Multiple system atrophy and pure autonomic failure
Authors:
- 10 January 2006
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 21 (5) , 609-615
Abstract
We assessed the effects of clonidine on blood pressure (BP) and heart rate (HR) in multiple system atrophy (MSA), where the autonomic nervous system lesion site is preganglionic, and in pure autonomic failure (PAF), where it is postganglionic. In normal subjects, intravenous infusion of the selective α2‐adrenoceptor agonist clonidine reduces BP and plasma noradrenaline (NA) levels by means of central α2‐adrenoceptor action, as well as inducing growth hormone (GH) release. Clonidine‐induced GH release is impaired in MSA but spared in PAF. However, the hemodynamic effects of clonidine have not been studied extensively in these disorders. We examined intravenous clonidine test results (performed in our autonomic laboratories using the London Autonomic Units protocol) in 58 patients: 39 with probable MSA and 19 with PAF. Systolic BP (SBP), diastolic BP (DBP), HR, and NA levels were measured supine at baseline and for up to 60 minutes after clonidine. Clonidine resulted in a significant BP fall in MSA patients, which occurred earlier (within 15 minutes of clonidine) and to a greater extent than seen in PAF patients. MSA and PAF patients showed reduction in HR after clonidine administration, although this finding was significantly greater in MSA than in PAF patients. NA levels decreased significantly after clonidine administration in both groups. Although basal NA levels were lower in PAF than in MSA patients, there was no difference in NA reduction relative to baseline between groups. MSA patients showed significant negative correlation between basal NA levels and BP response to clonidine. Clonidine infusion reduces BP and HR in both MSA and PAF groups but to a greater extent in MSA patients. The greater vasodepressor action of clonidine in MSA patients suggests that there is partial preservation of brainstem sympathetic outflow pathways in MSA and may reflect its action at sites in the brainstem and spinal cord that were in part functionally preserved in MSA. Despite similar degrees of NA reduction after clonidine administration, the vasodepressor effect of clonidine was attenuated in PAF compared with MSA patients. This attenuation in PAF patients may reflect greater peripheral α2‐adrenoceptor denervation supersensitivity due to the postganglionic lesion site. These BP differences, thus, may reflect the underlying lesion site in MSA and PAF, and the hemodynamic data after clonidine infusion may help differentiate these conditions. © 2006 Movement Disorder SocietyKeywords
This publication has 30 references indexed in Scilit:
- Cardiovascular Effects of Clonidine-Like Drugs in Pithed RabbitsHypertension, 1999
- Selective Antihypertensive Action of Moxonidine Is Mediated Mainly by I1-Imidazoline Receptors in the Rostral Ventrolateral MedullaJournal of Cardiovascular Pharmacology, 1994
- Growth hormone response to clonidine in central and peripheral primary autonomic failureThe Lancet, 1992
- Up-regulation ofβ-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjectsClinical Autonomic Research, 1992
- The imidazoline preferring receptor: binding studies in bovine, rat and human brainstemEuropean Journal of Pharmacology, 1989
- Ventrolateral medullary pressor area: site of hypotensive action of clonidineBrain Research, 1987
- Participation of a Bulbospinal Serotonergic Pathway in the Rat Brain in Clonidine-Induced Hypotension and BradycardiaPharmacology, 1987
- Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.Journal of Clinical Investigation, 1986
- Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agentsBrain Research Reviews, 1984
- Effects of clonidine and l-dopa on spontaneous and evoked splanchnic nerve dischargesEuropean Journal of Pharmacology, 1973